Twist Bioscience reported after the close of the market recently that revenues for its fiscal fourth quarter 2019 rose 87 percent year over year.... Read More >

Cancer drug developer Oncology Pharma said recently that it has signed a letter of intent to acquire at least 50 percent of molecular genomics firm Diagnomics.... Read More >

Prescient Medicine said this week that it has partnered with Dutch medical research institute Erasmus MC to evaluate its opioid addiction risk technology in a clinical study in the Netherlands.... Read More >

Horizon Discovery and Mammoth Biosciences announced recently that they will collaborate to develop new CRISPR tools, with the aim of generating new engineered cell lines for the biopharmaceutical industry. ... Read More >

Healthcare artificial intelligence firm Tempus announced earlier this week the acquisition of Akesogen, the owner of a commercial laboratory and provider of genomics and clinical trial precision medicine services.... Read More >

The National Institutes of Health has renewed funding for the Antibacterial Resistance Leadership Group (ARLG) with up to $102.5 million over seven years.... Read More >

After years developing technology to do multiplex testing for infectious diseases, Enigma Diagnostics shuttered about two years ago without much fanfare. But thanks to a former investor in the company, Enigma's technology may live on.... Read More >

Computational technology company Nvidia has acquired sequencing analysis software developer Parabricks. Terms were not disclosed. Read More >

Promega said on Thursday that it has signed a license agreement for MilliporeSigma's foundational CRISPR genome editing technology. Read More >

Curetis said after the close of the market on Friday that the US Food and Drug Administration has cleared the company's Unyvero LRT lower respiratory tract application cartridge for marketing in the US.... Read More >